课题基金 / 基金详情

Dendritic Cell Targeting of Anthrax Vaccine

Dendritic Cell Targeting of Anthrax Vaccine
炭疽疫苗的树突状细胞靶向
批准号:
6953777
负责人:
Mansour M Zadeh
金额:
$25.67万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2006-08-31

项目摘要

项目成果

Mansour M Zadeh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Anthrax poses a significant threat as an agent of biological warfare. The current anthrax vaccine (AVA) requires multiple doses over an 18 month period. Therefore, in addition to the current vaccine, improved anthrax vaccine strategies will offer the public health. Antibodies to the protective antigen (PA) play an important role in specific immunity to anthrax. However, cell mediated immune responses are also important. Professional antigen presenting dendritic cells (DCs) possess the ability to elicit both humoral and cellular immune responses. These cells are poised to capture pathogens, migrate to draining lymph nodes, and select antigen-specific T cells to regulate T, B, and NK cells, macrophages and eosinophils, all of which may contribute to protective immunity. The objective of this proposal is to develop a novel vaccine strategy targeting anthrax PA directly to DCs. Recently we have shown that DCs induce significant T cell activation in vivo and in vitro. Moreover, our preliminary data demonstrate that recombinant PA activates DCs, inducing up-regulation of co-stimulatory molecules, and LC migration in vivo. We have generated peptides that specifically bind to DC subsets from a phage display library. We hypothesize that targeting PA directly to DCs will increase the levels and duration of a specific immune response resulting in better protection against anthrax. Thus, we will target PA to DCs by fusing it to DC-specific peptides. The specific aims of this proposal are 1: To determine whether targeting PA specifically to DCs enhances specific immune responses against B. anthracis PA and 2: To test whether PA-DC peptide fusion protein delivered by subcutaneous administration induces strong immune responses in the immune competent cells. This novel vaccine strategy to target specifically immunogenic PA to DCs via DC-binding peptides may enhance the immunogenicity of PA and thus elicit stronger immune responses against PA of B. anthracis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis
Bacterial surface layer-specific immune protection against gut microbial infection
  • 批准号:
    9252460
  • 项目类别:
  • 资助金额:
    $33.95万
  • 财政年份:
    2016
  • 负责人:
    Mansour M Zadeh
  • 依托单位:
海外基金